Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroblastoma.

S Shah1, Y Ravindranath

  • 1Children's Hospital of Michigan, Department of Pediatric Hematology/Oncology, Detroit 48201, USA.

Indian Journal of Pediatrics
|April 25, 2000
PubMed
Summary
This summary is machine-generated.

Neuroblastoma, a pediatric cancer from neural crest cells, shows varied behaviors, including spontaneous regression and aggressive malignancy. Risk-stratified therapy is improving outcomes for high-risk neuroblastoma patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resolution of sweating after switching from transdermal fentanyl to oral morphine sulphate.

Palliative medicine·2006
Same author

Hepatic veno-occlusive disease due to tacrolimus in a single-lung transplant patient.

The European respiratory journal·2006
Same author

Homocysteine, estrogen and cognitive decline.

Climacteric : the journal of the International Menopause Society·2006
Same author

Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor.

The Journal of pharmacology and experimental therapeutics·2006
Same author

Review article: uncomplicated diverticular disease of the colon.

Alimentary pharmacology & therapeutics·2006
Same author

Sodium and potassium excretion in normotensive and hypertensive population in Kashmir.

The Journal of the Association of Physicians of India·2006
Same journal

Bilateral Parotid Enlargement as an Initial Manifestation of Pediatric Acute Lymphoblastic Leukemia.

Indian journal of pediatrics·2026
Same journal

Hemorrhagic Cardiac Tamponade Due to MRSA Sepsis in a Child with Relapsed Acute Lymphoblastic Leukemia: Authors' Reply.

Indian journal of pediatrics·2026
Same journal

A Prospective Model for Detecting Missed Appendicitis in Low-Risk Pediatric Patients: Correspondence.

Indian journal of pediatrics·2026
Same journal

Serum Periostin as a Biomarker in Pediatric Asthma: Findings from a Case-Control Study - Authors' Reply.

Indian journal of pediatrics·2026
Same journal

When the Eye Peels: An Unusual Harbinger of Kawasaki Disease - Correspondence.

Indian journal of pediatrics·2026
Same journal

Pediatric Sleep-Related Laryngospasm: Cause of Nocturnal Respiratory Distress.

Indian journal of pediatrics·2026
See all related articles

Area of Science:

  • Pediatric Oncology
  • Cancer Biology
  • Developmental Neuroscience

Background:

  • Neuroblastic tumors arise from neural crest cells, impacting the sympathetic nervous system and adrenal medulla.
  • Neuroblastoma presents a unique challenge in pediatric oncology due to its diverse clinical behaviors and natural history.
  • Despite high spontaneous regression rates in some cases, metastatic neuroblastoma in older children remains a significant therapeutic challenge with limited survival improvements over decades.

Purpose of the Study:

  • To explore the complex biology and clinical heterogeneity of neuroblastoma.
  • To highlight the challenges in improving outcomes for metastatic neuroblastoma in older children.
  • To emphasize the recent advancements in understanding neuroblastoma biology for risk-stratified therapeutic development.

Related Experiment Videos

Main Methods:

  • Review of existing literature on neuroblastoma biology and clinical presentation.
  • Analysis of historical treatment outcomes for pediatric neuroblastoma.
  • Integration of recent biological insights into therapeutic strategies.

Main Results:

  • Neuroblastoma exhibits a wide spectrum of behavior, from spontaneous regression to highly aggressive disease.
  • Significant progress in understanding neuroblastoma's biological underpinnings has been made.
  • Risk-related therapeutic approaches, considering age, stage, and biology, are emerging.

Conclusions:

  • Neuroblastoma remains a complex pediatric neoplasm requiring nuanced management.
  • Advances in molecular and biological understanding are crucial for developing effective, risk-adapted therapies.
  • Targeted therapies based on neuroblastoma's specific characteristics offer improved prognoses for affected children.